Aimmune Therapeutics Inc is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. AIMT has around 6.3M shares in the U.S. ETF market. The largest ETF holder of AIMT is the SPDR S&P Biotech ETF (XBI), with approximately 2.79M shares. Investors may also find of interest that the ETF with the largest allocation to AIMT stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 1.91%. On average, U.S. ETFs allocate 0.13% of AIMT to their portfolios.
Additionally, AIMT is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AIMT as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.